For World Hepatitis Day, please join us for presentations and a panel discussion on achieving hepatitis C elimination by 2030
Australia has committed to eliminating hepatitis C by 2030, with targets to increase diagnoses and treatment, and reduce new infections and liver-related deaths. Hepatitis C therapies with cure rates of over 95% are one of the greatest medical advances in decades, having led to declines in liver-related mortality. Our ability to meet the WHO targets in Australia is threatened by declines in annual hepatitis C RNA testing and treatment.
For World Hepatitis day, this special event will include presentations from the Kirby Institute; Hepatitis Australia; Australasian Society for HIV, Viral Hepatitis, and Sexual Health Medicine (ASHM); and Burnet Institute on efforts to help find, test, and treat people living with hepatitis C in Australia. The seminar will include a panel discussion on the key requirements that are needed to facilitate hepatitis C elimination as we approach 2030.